| JYHZ1800249 | 依巴斯汀片 | ebastine | Tablet | Chemical Drugs | License Renew | 2018-08-16 | 瑞士普利化学工业公司北京代表处 | Polichem SRLBeijing;Almirall SA | Certificate Issued | 2019-08-13 | view |
| JYHB1601394 | 依巴斯汀片 | ebastine | Tablet | Chemical Drugs | Supplementary Application | 2016-10-25 | 瑞士普利化学工业公司北京代表处 | Polichem SRLBeijing;Almirall SA;Industrias Farmaceuticas Almirall SA | Certificate Issued | 2018-06-29 | view |
| JYHB1901638 | 依巴斯汀片 | ebastine | Tablet | Chemical Drugs | Supplementary Application | 2020-01-23 | 瑞士普利化学工业公司北京代表处 | Polichem SRLBeijing;Almirall SA;Industrias Farmaceuticas Almirall SA | In Review | 2020-01-22 | view |
| A20020006 | 匹多莫德 | pidotimod | Active ingredient | Chemical Drugs | New Drug Application | 2004-05-26 | 普利化学工业公司北京代表处 | Polichem SRLBeijing | In Approval | | view |
| JYHB1201457 | 匹多莫德口服液 | pidotimod | Oral solution | Chemical Drugs | Supplementary Application | 2012-12-17 | 普利化学工业公司 | Polichem Srl;Doppel Farmaceutical Srl | Certificate Issued | 2015-12-23 | view |
| JYHB1800502 | 匹多莫德口服液 | pidotimod | Oral solution | Chemical Drugs | Supplementary Application | 2018-04-26 | 普利化学工业公司 | Polichem Srl;Doppel Farmaceutical Srl | Filed | 2018-05-14 | view |
| JYHZ2000152 | 匹多莫德口服液 | pidotimod | Oral solution | Chemical Drugs | License Renew | 2020-06-25 | 瑞士普利化学工业公司北京代表处 | Polichem SRLBeijing;Polichem Srl;Doppel Farmaceutical Srl | In Review | 2020-06-24 | view |
| JYHB1800106 | 匹多莫德口服液 | pidotimod | Oral solution | Chemical Drugs | Supplementary Application | 2018-02-02 | 普利化学工业公司 | Polichem Srl;Doppel Farmaceutical Srl | Filed | 2018-03-09 | view |
| JYHB1601541 | 匹多莫德口服液 | pidotimod | Oral solution | Chemical Drugs | Supplementary Application | 2016-11-30 | 普利化学工业公司 | Polichem Srl;Doppel Farmaceutical Srl | Certificate Issued | 2021-02-18 | view |
| JBHR1500001 | 环吡酮胺阴道栓 | ciclopirox | Suppository | Chemical Drugs | State Standards | 2015-02-11 | 普利化学工业公司 | Polichem Srl;Doppel Farmaceutical Srl | Certificate Issued | 2017-01-20 | view |
| JYHB1201541 | 环吡酮胺阴道栓 | ciclopirox | Suppository | Chemical Drugs | Supplementary Application | 2012-12-27 | 普利化学工业公司 | Polichem Srl;Doppel Farmaceutical Srl | Certificate Issued | 2014-11-14 | view |
| JYHB1201538 | 环吡酮胺阴道软膏 | ciclopirox | Ointment | Chemical Drugs | Supplementary Application | 2012-12-27 | 普利化学工业公司 | Polichem Srl;Doppel Farmaceutical Srl | Certificate Issued | 2014-11-14 | view |
| JBHR1500002 | 环吡酮胺阴道软膏 | ciclopirox | Ointment | Chemical Drugs | State Standards | 2015-03-25 | 普利化学工业公司 | Polichem Srl;Doppel Farmaceutical Srl | Certificate Issued | 2016-12-12 | view |
| JYHZ1400305 | 甲磺酸-a-二氢麦角隐亭片 | Dihydro-α-ergocryptine Mesylate | Tablet | Chemical Drugs | License Renew | 2014-12-02 | 普利化学工业公司 | Polichem Srl;Doppel Farmaceutical Srl | Certificate Issued | 2017-09-19 | view |
| J0300660 | 甲磺酸-α- 二氢麦角隐亭 | Dihydro-α-ergocryptine Mesylate | Active ingredient | Chemical Drugs | Supplementary Application | 2004-08-09 | 普利化学工业公司 | Polichem Srl;Polichem SRLBeijing | Pending Approval | 2005-01-24 | view |
| J0300661 | 甲磺酸-α-二氢麦角隐亭 | Dihydro-α-ergocryptine Mesylate | Active ingredient | Chemical Drugs | Supplementary Application | 2004-08-05 | 普利化学工业公司 | Polichem Srl;Polichem SRLBeijing | Pending Approval | 2005-01-24 | view |
| J0300805 | 甲磺酸-α-二氢麦角隐亭p=片 | Dihydro-α-ergocryptine Mesylate | Tablet | Chemical Drugs | License Renew | 2004-04-09 | 普利化学工业公司 | Polichem Srl;Polichem SRLBeijing;Doppel Farmaceutical Srl | Certificate Issued | 2004-11-12 | view |
| J0300804 | 甲磺酸-α-二氢麦角隐亭胶囊 | Dihydro-α-ergocryptine Mesylate | Capsule | Chemical Drugs | License Renew | 2004-04-09 | 普利化学工业公司 | Polichem Srl;Polichem SRLBeijing;Doppel Farmaceutical Srl | Certificate Issued | 2004-11-12 | view |
| A20020007 | 硝呋太尔 | nifuratel | Active ingredient | Chemical Drugs | New Drug Application | 2004-02-18 | 普利化学工业公司北京代表处 | Polichem SRLBeijing | Approval Completed-Pending Certificated | | view |
| JYHZ1500143 | 硝呋太尔-制霉菌素阴道栓 | nifuratel;nystatin | Suppository | Chemical Drugs | License Renew | 2015-09-02 | 普利化学工业公司 | Polichem Srl;Doppel Farmaceutical Srl | Certificate Issued | 2018-08-06 | view |
